| 2C3I: reference: Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity., Pogacic V, Bullock AN, Fedorov O, Filippakopoulos P, Gasser C, Biondi A, Meyer-Monard S, Knapp S, Schwaller J, Cancer Res. 2007 Jul 15;67(14):6916-24. PMID: 17638903 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).